Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.
byBenzinga Newsdesk
August 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview For Telefonica Brasil

By Benzinga Insights
July 25, 7:24 PM
Telefonica Brasil (NYSE:VIV) is set to give its latest quarterly earnings report on Tuesday, 2022-07-26. Here's what investors need to know before the announcement. Analysts estimate that Telefonica Brasil will report an earnings per share (EPS) of $0.13.

VIV